Tonix Pharmaceuticals, Inc.

Quick facts

Phase 2 pipeline

• TNX-1900
• TNX-201
• TNX-601 ER

Phase 1 pipeline

• Cyclobenzaprine IV
• Cyclobenzaprine tablets
• Racemic isometheptene 70 mg
• SL TNX-102 at 2.4 mg
• TNX-201 35 mg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Tonix Pharmaceuticals, Inc. portfolio CI brief
• Tonix Pharmaceuticals, Inc. pipeline updates RSS